PROTEINURIC KIDNEY DISEASE
Clinical trials for PROTEINURIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for PROTEINURIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney disease: drug targets genetic root cause
Disease control Recruiting nowThis study tests an experimental drug called MZE829 in 56 adults with chronic kidney disease caused by a specific genetic risk (APOL1). The goal is to see if the drug can reduce protein leakage into urine (a sign of kidney damage) and is safe. Participants must have the high-risk…
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Maze Therapeutics • Aim: Disease control
Last updated May 17, 2026 12:45 UTC
-
New drug targets genetic kidney disease in landmark trial
Disease control Recruiting nowThis study tests an experimental drug called VX-147 in people with a type of kidney disease caused by a specific gene change (APOL1). The goal is to see if the drug can reduce protein in the urine and protect kidney function. About 466 adults and children will take either VX-147 …
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 11, 2026 20:41 UTC